Cargando…
Accelerated antibody discovery targeting the SARS-CoV-2 spike protein for COVID-19 therapeutic potential
BACKGROUND: Rapid deployment of technologies capable of high-throughput and high-resolution screening is imperative for timely response to viral outbreaks. Risk mitigation in the form of leveraging multiple advanced technologies further increases the likelihood of identifying efficacious treatments...
Autores principales: | Mullen, Tracey E, Abdullah, Rashed, Boucher, Jacqueline, Brousseau, Anna Susi, Dasuri, Narayan K, Ditto, Noah T, Doucette, Andrew M, Emery, Chloe, Gabriel, Justin, Greamo, Brendan, Patil, Ketan S, Rothenberger, Kelly, Stolte, Justin, Souders, Colby A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444149/ https://www.ncbi.nlm.nih.gov/pubmed/34541454 http://dx.doi.org/10.1093/abt/tbab018 |
Ejemplares similares
-
Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform
por: Shapiro, Mariya B, et al.
Publicado: (2023) -
Considerations for Bedside Urologic Procedures in Patients With Severe Acute Respiratory Syndrome Coronavirus-2
por: Souders, Colby P., et al.
Publicado: (2020) -
Low Rates of Urologic Side Effects Following Coronavirus Disease Vaccination: An Analysis of the Food and Drug Administration Vaccine Adverse Event Reporting System
por: Zhao, Hanson, et al.
Publicado: (2021) -
AUTHOR REPLY
por: Zhao, Hanson, et al.
Publicado: (2020) -
Adverse Events Associated With Synthetic Male Slings: An Analysis of the Food and Drug Administration Manufacturer and User Facility Device Experience Database
por: Zhao, Hanson, et al.
Publicado: (2021)